BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 8975111)

  • 21. [Botulinum toxin therapy for focal dystonia].
    Hahn K; Niklai E; Garzuly F; Szupera Z
    Orv Hetil; 2009 Jul; 150(29):1381-4. PubMed ID: 19581172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.
    Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G
    J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Own experience with botulinum treatment of dystonia].
    Domzał T
    Neurol Neurochir Pol; 1995; 29(4):481-8. PubMed ID: 8544926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern non-cosmetic treatment with botulinum toxins].
    Straube A
    Internist (Berl); 2017 Dec; 58(12):1332-1340. PubMed ID: 29030680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin in movement disorders.
    Papapetropoulos S; Singer C
    Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic application of botulinum toxin.
    Hambleton D
    J Med Microbiol; 1993 Oct; 39(4):243-5. PubMed ID: 8411083
    [No Abstract]   [Full Text] [Related]  

  • 30. Botulinum toxin: a dreaded toxin for use in human being.
    Ghosh B; Das SK
    J Indian Med Assoc; 2002 Oct; 100(10):607-8, 610-2, 614. PubMed ID: 12452515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of movement disorders using botulinum toxin].
    Burgunder JM
    Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical application of botulinum toxin].
    Mezaki T
    Brain Nerve; 2011 Jul; 63(7):785-94. PubMed ID: 21747149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
    Greene PE; Fahn S
    Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Spasmodic torticollis: experience of 5 years with botulinum toxin treatment].
    Domzał TM
    Neurol Neurochir Pol; 1999; 33(2):351-7. PubMed ID: 10463249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulism toxin in practice].
    Durand A; Serment G
    Ann Readapt Med Phys; 2003 Jul; 46(6):386-8. PubMed ID: 12928147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm.
    Brin MF; Fahn S; Moskowitz C; Friedman A; Shale HM; Greene PE; Blitzer A; List T; Lange D; Lovelace RE
    Mov Disord; 1987; 2(4):237-54. PubMed ID: 3504553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of treating dystonias and hemifacial spasm with botulinum toxin A.
    Dodel RC; Kirchner A; Koehne-Volland R; Künig G; Ceballos-Baumann A; Naumann M; Brashear A; Richter HP; Szucs TD; Oertel WH
    Pharmacoeconomics; 1997 Dec; 12(6):695-706. PubMed ID: 10175981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.